Welcome to our dedicated page for Lemonade SEC filings (Ticker: LMND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Lemonade, Inc. (NYSE: LMND) SEC filings, offering a view into how the digital insurer reports its business, risks, and governance. Lemonade operates full stack insurance carriers in the US and EU and offers renters, homeowners, car, pet, and life insurance powered by artificial intelligence and social impact. Its filings with the U.S. Securities and Exchange Commission detail financial results, material agreements, and board-level changes.
Investors can review current and historical reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which include discussions of risk factors like profitability, reinsurance availability, regulatory oversight, reliance on artificial intelligence and telematics, catastrophe exposure, and its status as a public benefit corporation and Certified B-Corp. These reports also describe how Lemonade uses technology, data, and reinsurance to support its property and casualty insurance operations.
Current reports on Form 8-K highlight specific events, including earnings announcements via shareholder letters, entry into material definitive agreements such as its reinsurance program with reinsurers Hannover Ruck SE and MAPFRE Re, and appointments of new directors to the board. These filings outline key terms of reinsurance arrangements, changes in quota share levels, and compensation structures for non-employee directors.
On Stock Titan, Lemonade’s SEC filings are updated in near real time as they appear on EDGAR. AI-powered summaries help explain lengthy documents by extracting the main points from 10-K and 10-Q reports, clarifying complex risk disclosures and business descriptions. Users can also review Form 8-K items related to results of operations, governance changes, and material contracts, as well as monitor other filing types and any reported insider-related information through the underlying SEC documents.
Lemonade, Inc. is having its warrants to purchase common stock removed from listing and registration on the NYSE American. The exchange states it has followed its rules to strike this class of securities, and the company has complied with the exchange’s requirements for voluntary withdrawal.
Lemonade, Inc. insider transaction: An entity associated with Chief Executive Officer Daniel Schreiber, Dan and Dan Ltd., sold 9,108 shares of Lemonade common stock on January 23, 2026 at a weighted average price of $99.04 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on December 11, 2024. After this transaction, 1,514,426 shares of Lemonade common stock were beneficially owned indirectly through Dan and Dan Ltd., over which Schreiber has voting and dispositive control.
Lemonade, Inc. filed an update on its publicly traded warrants that were originally issued in connection with its November 8, 2021 merger with Metromile, Inc. The company has 7,846,646 warrants outstanding, each with an exercise price of $218.51 and listed on the New York Stock Exchange under the symbol LMND-WS.
These warrants are scheduled to expire on Monday, February 9, 2026 at 5:00 p.m. Eastern Time. To allow for timely settlement of any final trades, the New York Stock Exchange has notified Lemonade that it will suspend trading of the warrants after the close of market on Thursday, February 5, 2026.
Lemonade, Inc. insider reporting shows that Dan and Dan Ltd., an entity controlled by Chief Executive Officer and director Daniel A. Schreiber, sold 126,625 shares of common stock on January 22, 2026. The sale was made under a Rule 10b5-1 trading plan that was adopted on December 11, 2024, meaning the trades were pre-arranged according to preset instructions.
The filing reports a weighted average sale price of $94.74 per share, with the shares sold in multiple transactions. After this transaction, 1,523,534 shares of Lemonade common stock are reported as beneficially owned indirectly, held by Dan and Dan Ltd., over which Schreiber has voting and dispositive control.
Lemonade, Inc. reported that Chief Insurance Officer John Sheldon Peters sold common stock in a planned transaction. On January 22, 2026, he sold 9,000 shares of common stock at $90 per share in an open market sale coded as a disposition. The transaction was executed under a Rule 10b5-1 trading plan adopted on August 22, 2025, indicating it was pre-arranged rather than opportunistic.
Following this sale, Peters beneficially owns 70,228 shares of Lemonade common stock, held directly. The filing shows no derivative securities activity in this period.
A shareholder of the issuer for LMND has filed a notice of proposed sale under Rule 144 covering 144,000 shares of common stock to be sold through Goldman Sachs & Co. LLC. The filing lists an aggregate market value of $13,906,080 for these shares and notes that 74,731,027 shares of the class were outstanding, with an approximate sale date of January 22, 2026 on the NYSE. The notice also reports that 35,000 common shares were sold during the prior three months by Daniel Schreiber for $2,769,900 in gross proceeds.
A shareholder of LMND has filed a Rule 144 notice to sell 9,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 01/22/2026. The shares to be sold have an indicated aggregate market value of
The 9,000 shares were acquired on 01/02/2025 via a stock option exercise from the issuer, paid in cash. The filing also lists prior sales over the past three months by John S. Peters, including a sale of 10,000 shares on 01/06/2026 for
JPMorgan Chase & Co. reported a passive ownership stake in Lemonade, Inc. common stock as of 12/31/2025. The firm disclosed beneficial ownership of 4,482,950 shares, representing 5.9% of the class. JPMorgan has sole voting power over 2,306,747 shares and shared voting power over 43 shares, with sole dispositive power over 4,477,816 shares and shared dispositive power over 4,464 shares.
The filing is made on a Schedule 13G basis, meaning JPMorgan certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Lemonade.
Lemonade, Inc. reported an insider equity transaction by Chief Insurance Officer John Sheldon Peters. On January 8, 2026, Peters exercised a stock option to acquire 18,457 shares of Lemonade common stock at an exercise price of
After the transaction, Peters beneficially owned 79,228 shares of Lemonade common stock in direct form and held 10,000 stock options directly. The filing notes that the option involved in the transaction was fully vested and exercisable.
Lemonade, Inc. disclosed that Chief Insurance Officer John Peters sold shares of company stock. On January 6, 2026, he sold 10,000 shares of common stock at $80 per share in a planned transaction under a Rule 10b5-1 trading plan adopted on August 22, 2025. After this sale, he directly owned 60,771 shares of Lemonade common stock.